January 13th 2024
Focusing on efficient gene delivery of NK cells, The First Condor Life and OBiO Technology reach a strategic cooperation!
The First Condor Life and OBiO Technology have reached a strategic cooperation. In this collaboration, The First Condor Life and OBiO Technology will share resources, complement each other's advantages, jointly address market changes and competitive pressures, and achieve win-win cooperation and sustainable development.
On December 27th, Shenzhen First Condor Life Science Co. Ltd. (hereinafter referred to as " First Condor Life") in Shenzhen and OBiO Biotechnology (Shanghai) Co., Ltd. (stock code: 688238) (hereinafter referred to as " OBiO Biotech") signed a strategic cooperation agreement in Lingang, Shanghai. First Condor Life's co-founder and CTO, Maria Ma, Quality Director Liu Dong, Early R&D Director Wang Zhongsheng, CAR-NK Platform Head Huang Jing, OBiO Biotech CEO Jia Guodong, Deputy General Manager Yin Shan, and Marketing Director Wang Yao attended the signing ceremony."